# Referencias — razones de prevalencia por sexo (diapositiva 2)

Fuentes de las razones de prevalencia usadas en el gráfico de contexto
epidemiológico. Copiar tal cual a `docs/referencias.md`. No agregar, no reformular,
no inventar.

1. Hiller, R. M., Young, R. L. & Weber, N. Sex differences in pre-diagnosis concerns
   for children later diagnosed with autism spectrum disorder. *Autism* **20**,
   75–84 (2016).
2. Catalá-López, F. et al. Prevalence of attention deficit hyperactivity disorder
   among children and adolescents in Spain: a systematic review and meta-analysis of
   epidemiological studies. *BMC Psychiatry* **12**, (2012).
3. Goldstein, J. M., Cherkerzian, S., Tsuang, M. T. & Petryshen, T. L. Sex
   differences in the genetic risk for schizophrenia: history of the evidence for
   sex-specific and sex-dependent effects. *Am. J. Med. Genet. B. Neuropsychiatr.
   Genet.* **162B**, 698–710 (2013).
4. Elbaz, A. et al. Risk tables for parkinsonism and Parkinson's disease. *J. Clin.
   Epidemiol.* **55**, 25–31 (2002).
5. McCombe, P. A. & Henderson, R. D. Effects of gender in amyotrophic lateral
   sclerosis. *Gend. Med.* **7**, 557–570 (2010).
6. Ferretti, M. T. et al. Sex differences in Alzheimer disease — the gateway to
   precision medicine. *Nat. Rev. Neurol.* **14**, 457–469 (2018).
7. Voskuhl, R. R. & Gold, S. M. Sex-related factors in multiple sclerosis
   susceptibility and progression. *Nat. Rev. Neurol.* **8**, 255–263 (2012).
8. Voskuhl, R. R. The effect of sex on multiple sclerosis risk and disease
   progression. *Mult. Scler. J.* **26**, 554–560 (2020).
9. Altemus, M., Sarvaiya, N. & Neill Epperson, C. Sex differences in anxiety and
   depression clinical perspectives. *Front. Neuroendocrinol.* **35**, 320–330
   (2014).
10. Faravelli, C., Alessandra Scarpato, M., Castellini, G. & Lo Sauro, C. Gender
    differences in depression and anxiety: The role of age. *Psychiatry Res.*
    **210**, 1301–1303 (2013).